OTC · Drug Manufacturers - Specialty & Generic

Elixinol Wellness Limited (ELLXF) Stock

$0.01 +0.00% OTC: ELLXF Healthcare

Elixinol Wellness Limited, an Australian-based company established in 2017 with its headquarters in Sydney, operates as a global producer and supplier of hemp-derived products. The firm crafts and distributes a diverse range of hemp-based wellness, beauty, and food items, marketed under its well-known Elixinol and Hemp Foods Australia brands.

Valuation

MetricValue
Price$0.01
Market Cap$1.63M
P/E Ratio-0.28
P/B Ratio0.26
P/S Ratio0.08
EPS (TTM)$-0.02
52-Week High$0.03
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-76.30%
ROA-34.45%
ROCE-47.65%
Gross Margin20.00%
Operating Margin-28.62%
Net Margin-35.43%
Debt/Equity0.50
Current Ratio0.86

Annual Financials (USD)

Metric20212022202320242025
Revenue$9.0M$7.0M$8.0M$15.0M$15.0M
Operating Profit$-16.0M$-10.0M$-6.0M$-5.0M$-5.0M
Net Profit$-17.0M$-11.0M$-8.0M$-2.0M$-5.0M
EPS$-0.04$-0.03$-0.10$-0.01$-0.02
Op Margin-167.2%-141.8%-78.2%-34.1%-32.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$25.0M$13.0M$12.0M$18.0M$16.0M
Total Liabilities$6.0M$4.0M$5.0M$8.0M$9.0M
Cash$13.0M$3.0M$1.0M$1.0M$1.0M
Borrowings$3.0M$2.0M$1.0M$2.0M$4.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-8.0M$-3.0M$-3.0M$-3.0M
Investing Cash Flow$0$-1.0M$-1.0M$2.0M$0
Financing Cash Flow$-1.0M$-1.0M$-1.0M$-2.0M$0
Net Cash Flow$-15.0M$-10.0M$-2.0M$0$0
Free Cash Flow$-14.0M$-8.0M$-3.0M$-4.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.79
FCF Yield-251.38%
Quick Ratio0.46
Interest Coverage-9.10
Return 1Y-73.21%
Return 3Y-89.41%
Return 5Y—

Ownership

Insiders Held33.06%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CSUICannabis Suisse Corp. $0.01 -4.49% 5.67 $600788 0.00%
IDCNIndocan Resources Inc. $0.00 — — $74079 0.00%
NGMCNext Generation Management Corp. $0.10 +0.00% 0.00 $31163 0.00%
NPHCNutra Pharma Corp. $0.00 — -1.00 $2.15M 0.00%
NRXCFNeutriSci International Inc. $0.00 — -1.09 $653980 0.00%

About Elixinol Wellness Limited

Elixinol Wellness Limited, an Australian-based company established in 2017 with its headquarters in Sydney, operates as a global producer and supplier of hemp-derived products. The firm crafts and distributes a diverse range of hemp-based wellness, beauty, and food items, marketed under its well-known Elixinol and Hemp Foods Australia brands. Its comprehensive product portfolio encompasses cannabidiol (CBD) products, dietary supplements, various food items, topicals, and skincare solutions. These offerings reach consumers across significant international markets, including the Americas, Europe, and Australia. The company officially adopted its current name, Elixinol Wellness Limited, in May 2021, having previously been known as Elixinol Global Limited.

Elixinol Wellness Limited is headquartered in AU.

Elixinol Wellness Limited (ELLXF) stock trades at $0.01 with a market capitalization of $1.63M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.28, reflecting a net loss over the last twelve months, price-to-book of 0.26, price-to-sales of 0.08. Over the past 52 weeks the stock has ranged between $0.00 and $0.03, and currently trades 66.7% below its 52-week high.

On profitability, Elixinol Wellness Limited generates a return on equity (ROE) of -76.30% (negative, reflecting a net loss), return on capital employed of -47.65%, an operating margin of -28.62%, a net profit margin of -35.43%.

Official website: www.elixinolwellness.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.